Differentially methylated loci distinguish ovarian carcinoma histological types: Evaluation of a DNA methylation assay in FFPE tissue

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Kelemen, Linda E ^a,b   Köbel, Martin ^b,c   Chan, Angela ^d   Taghaddos, Soreh ^e   Dinu, Irina ^e  

^a ALBERTA HEALTH SERVICES   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c CALGARY LABORATORY SERVICES   (Canada)

^d TOM BAKER CANCER CENTRE   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOSPONDIN 2; TRANSCRIPTION FACTOR ERG; DNA;

ARTICLE; CANCER GENETICS; CANCER GRADING; CANCER PATIENT; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA EXTRACTION; DNA METHYLATION; ENDOMETRIOID CARCINOMA; FEMALE; GENE EXPRESSION; GENE LOCUS; HAPLOTYPE MAP; HISTOLOGY; HUMAN; HUMAN TISSUE; OVARY CARCINOMA; QUALITY CONTROL; REPRODUCIBILITY; X CHROMOSOME; CLINICAL TRIAL; GENE EXPRESSION REGULATION; METABOLISM; OVARY TUMOR; PATHOLOGY;

DNA METHYLATION; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC LOCI; HUMANS; OVARIAN NEOPLASMS;

EID: 84885660033     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/815894     Document Type: Article

References (67)

1. Jones P. A., Baylin S. B., The epigenomics of cancer. Cell 2007 128 4 683 692 2-s2.0-33847065486 10.1016/j.cell.2007.01.029 (Pubitemid 46273572)
2. Feinberg A. P., Epigenetics at the epicenter of modern medicine. Journal of the American Medical Association 2008 299 11 1345 1350 2-s2.0-40949093544 10.1001/jama.299.11.1345 (Pubitemid 351439080)
3. Mohandas T., Sparkes R. S., Shapiro L. J., Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science 1981 211 4480 393 396 2-s2.0-0019510628 (Pubitemid 11128749)
4. Antequerra F., Boyes J., Bird A., High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 1990 62 3 503 514 2-s2.0-0025006860 10.1016/0092-8674(90)90015-7 (Pubitemid 20263220)
5. Pulford D. J., Falls J. G., Killian J. K., Jirtle R. L., Polymorphisms, genomic imprinting and cancer susceptibility. Mutation Research 1999 436 1 59 67 2-s2.0-0032898879 10.1016/S1383-5742(98)00018-0 (Pubitemid 29044046)
6. Bird A., DNA methylation patterns and epigenetic memory. Genes and Development 2002 16 1 6 21 2-s2.0-0036144048 10.1101/gad.947102 (Pubitemid 34049633)
7. Lister R., Pelizzola M., Dowen R. H., Hawkins R. D., Hon G., Tonti-Filippini J., Nery J. R., Lee L., Ye Z., Ngo Q.-M., Edsall L., Antosiewicz-Bourget J., Stewart R., Ruotti V., Millar A. H., Thomson J. A., Ren B., Ecker J. R., Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009 462 7271 315 322 2-s2.0-70450217879 10.1038/nature08514
8. Illingworth R. S., Bird A. P., CpG islands-'a rough guide'. FEBS Letters 2009 583 11 1713 1720 2-s2.0-67349255210 10.1016/j.febslet.2009.04.012
9. Murphy S. K., Targeting the epigenome in ovarian cancer. Future Oncology 2012 8 2 151 164 2-s2.0-84857348466 10.2217/fon.11.152
10. Irizarry R. A., Ladd-Acosta C., Wen B., Wu Z., Montano C., Onyango P., Cui H., Gabo K., Rongione M., Webster M., Ji H., Potash J. B., Sabunciyan S., Feinberg A. P., The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nature Genetics 2009 41 2 178 186 2-s2.0-59149084538 10.1038/ng.298
11. Feinberg A. P., Ohlsson R., Henikoff S., The epigenetic progenitor origin of human cancer. Nature Reviews Genetics 2006 7 1 21 33 2-s2.0-29244469466 10.1038/nrg1748 (Pubitemid 41828945)
12. Hansen K. D., Timp W., Bravo H. C., Sabunciyan S., Langmead B., McDonald O. G., Wen B., Wu H., Liu Y., Diep D., Briem E., Zhang K., Irizarry R. A., Feinberg A. P., Increased methylation variation in epigenetic domains across cancer types. Nature Genetics 2011 43 8 768 775 2-s2.0-79960927422 10.1038/ng.865
13. Ferlay J., Shin H.-R., Bray F., Forman D., Mathers C., Parkin D. M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 2010 127 12 2893 2917 2-s2.0-78049485263 10.1002/ijc.25516
14. Auersperg N., Wong A. S. T., Choi K.-C., Kang S. K., Leung P. C. K., Ovarian surface epithelium: biology, endocrinology, and pathology. Endocrine Reviews 2001 22 2 255 288 2-s2.0-0035008525 10.1210/er.22.2.255 (Pubitemid 32458162)
15. Köbel M., Kalloger S. E., Huntsman D. G., Santos J. L., Swenerton K. D., Seidman J. D., Gilks C. B., Differences in tumor type in low-stage versus high-stage ovarian carcinomas. International Journal of Gynecological Pathology 2010 29 3 203 211 2-s2.0-77951702294 10.1097/PGP.0b013e3181c042b6
16. Wong K.-K., Gershenson D., The continuum of serous tumors of low malignant potential and low-grade serous carcinomas of the ovary. Disease Markers 2007 23 5-6 377 387 2-s2.0-36448982529 (Pubitemid 350171263)
17. Shih I.-M., Kurman R. J., Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. American Journal of Pathology 2004 164 5 1511 1518 2-s2.0-1942469352 (Pubitemid 38529752)
18. Singer G., Stöhr R., Cope L., Dehari R., Hartmann A., Cao D.-F., Wang T.-L., Kurman R. J., Shih I.-M., Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation. American Journal of Surgical Pathology 2005 29 2 218 224 2-s2.0-12844251290 10.1097/01.pas.0000146025.91953.8d (Pubitemid 40170640)
19. Roh M. H., Kindelberger D., Crum C. P., Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin? American Journal of Surgical Pathology 2009 33 3 376 383 2-s2.0-62849095422 10.1097/PAS.0b013e3181868904
20. Barton C. A., Hacker N. F., Clark S. J., O'Brien P. M., DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment. Gynecologic Oncology 2008 109 1 129 139 2-s2.0-40949087119 10.1016/j.ygyno.2007.12.017
21. Bell D., Berchuck A., Birrer M., Integrated genomic analyses of ovarian carcinoma. Nature 2011 474 7353 609 615
22. Press J. Z., De Luca A., Boyd N., Young S., Troussard A., Ridge Y., Kaurah P., Kalloger S. E., Blood K. A., Smith M., Spellman P. T., Wang Y., Miller D. M., Horsman D., Faham M., Gilks C. B., Gray J., Huntsman D. G., Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities. BMC Cancer 2008 8, article 17 2-s2.0-39549091276 10.1186/1471-2407-8-17 (Pubitemid 351279967)
23. Rathi A., Virmani A. K., Schorge J. O., Elias K. J., Maruyama R., Minna J. D., Mok S. C., Girard L., Fishman D. A., Gazdar A. F., Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women. Clinical Cancer Research 2002 8 11 3324 3331 2-s2.0-0036847546 (Pubitemid 35340705)
24. Strathdee G., Appleton K., Illand M., Millan D. W. M., Sargent J., Paul J., Brown R., Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. American Journal of Pathology 2001 158 3 1121 1127 2-s2.0-0035099160 (Pubitemid 32221804)
25. Esteller M., Corn P. G., Baylin S. B., Herman J. G., A gene hypermethylation profile of human cancer. Cancer Research 2001 61 8 3225 3229 2-s2.0-0035870248 (Pubitemid 32695003)
26. Wang C., Horiuchi A., Imai T., Ohira S., Itoh K., Nikaido T., Katsuyama Y., Konishi I., Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene. Journal of Pathology 2004 202 2 215 223 2-s2.0-1142311552 10.1002/path.1507 (Pubitemid 38208659)
27. Collins N., Wooster R., Stratton M. R., Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers. British Journal of Cancer 1997 76 9 1150 1156 2-s2.0-0030818584 (Pubitemid 27448010)
28. Gras E., Cortes J., Diez O., Alonso C., Matias-Guiu X., Baiget M., Prat J., Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors. Cancer 2001 92 4 787 795 (Pubitemid 32783064)
29. Hilton J. L., Geisler J. P., Rathe J. A., Hattermann-Zogg M. A., Deyoung B., Buller R. E., Inactivation of BRCA1 and BRCA2 in ovarian cancer. Journal of the National Cancer Institute 2002 94 18 1396 1406 2-s2.0-0037130885 (Pubitemid 35154144)
30. Costello J. F., Frühwald M. C., Smiraglia D. J., Rush L. J., Robertson G. P., Gao X., Wright F. A., Feramisco J. D., Peltomäki P., Lang J. C., Schuller D. E., Yu L., Bloomfield C. D., Caligiuri M. A., Yates A., Nishikawa R., Su Huang H.-J., Petrelli N. J., Zhang X., O'Dorisio M. S., Held W. A., Cavenee W. K., Plass C., Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nature Genetics 2000 24 2 132 138 2-s2.0-0343621494 10.1038/72785 (Pubitemid 30094712)
31. Killian J. K., Bilke S., Davis S., Walker R. L., Hipp J. D., Pittaluga S. X., Raffeld M., Smith W. I., Bibikova M., Fan J., Emmert-Buck M. R., Jaffe E. S., Meltzer P. S., In Genome-wide methylation profile of follicular lymphoma reveals distinct on- and off-island epigenotype [abstract no 32]. Proceedings of the 99th Annual Meeting of the American Association for Cancer Research April 2008 San Diego, Calif, USA AACR
32. Illumina, Inc.,. Methylation profiling of FFPE samples. Technical Note: Illumina Epigenetics, 2008, http://www.illumina.com
33. Bibikova M., Lin Z., Zhou L., Chudin E., Garcia E. W., Wu B., Doucet D., Thomas N. J., Wang Y., Vollmer E., Goldmann T., Seifart C., Jiang W., Barker D. L., Chee M. S., Floros J., Fan J.-B., High-throughput DNA methylation profiling using universal bead arrays. Genome Research 2006 16 3 383 393 2-s2.0-33644649616 10.1101/gr.4410706 (Pubitemid 43327509)
34. Ladd-Acosta C., Pevsner J., Sabunciyan S., Yolken R. H., Webster M. J., Dinkins T., Callinan P. A., Fan J.-B., Potash J. B., Feinberg A. P., DNA methylation signatures within the human brain. American Journal of Human Genetics 2007 81 6 1304 1315 2-s2.0-36749052947 10.1086/524110 (Pubitemid 350211460)
35. The International HapMap Consortium, The international HapMap project. Nature 2003 426 6968 789 796
36. Houshdaran S., Hawley S., Palmer C., Campan M., Olsen M. N., Ventura A. P., Knudsen B. S., Drescher C. W., Urban N. D., Brown P. O., Laird P. W., DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines. PLoS ONE 2010 5 2 2-s2.0-77949574043 10.1371/journal.pone.0009359 e9359
37. Steemers F. J., Gunderson K. L., Illumina, Inc. Pharmacogenomics 2005 6 7 777 782 2-s2.0-26944467896 10.2217/14622416.6.7.777 (Pubitemid 41479421)
38. Oliphant A., Barker D. L., Stuelpnagel J. R., Chee M. S., BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping. BioTechniques 2002 32 6 S56 S61 2-s2.0-0036275126 (Pubitemid 34615025)
39. Bjornsson H. T., Sigurdsson M. I., Fallin M. D., Irizarry R. A., Aspelund T., Cui H., Yu W., Rongione M. A., Ekström T. J., Harris T. B., Launer L. J., Eiriksdottir G., Leppert M. F., Sapienza C., Gudnason V., Feinberg A. P., Intra-individual change over time in DNA methylation with familial clustering. Journal of the American Medical Association 2008 299 24 2877 2883 2-s2.0-45849127657 10.1001/jama.299.24.2877 (Pubitemid 351930887)
40. Carrel L., Willard H. F., X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 2005 434 7031 400 404 2-s2.0-15244353967 10.1038/nature03479 (Pubitemid 40469185)
41. Tusher V. G., Tibshirani R., Chu G., Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences of the United States of America 2001 98 9 5116 5121 2-s2.0-0035942271 10.1073/pnas.091062498 (Pubitemid 32397092)
42. Tavassoulu F. A., Devilee P., World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Breast and Female Genital Organs 2003 Lyon, France IARC Press
43. Kalloger S. E., Köbel M., Leung S., Mehl E., Gao D., Marcon K. M., Chow C., Clarke B. A., Huntsman D. G., Gilks C. B., Calculator for ovarian carcinoma subtype prediction. Modern Pathology 2011 24 4 512 521 2-s2.0-79953295123 10.1038/modpathol.2010.215
44. Shen H., Fridley B. L., Song H., Lawrenson K., Cunningham J. M., Ramus S. J., Cicek M. S., Tyrer J., Stram D., Larson M. C., Kobel M., Ziogas A., Zheng W., Yang H. P., Wu A. H., Wozniak E. L., Woo Y. L., Winterhoff B., Wik E., Whittemore A. S., Wentzensen N., Weber R. P., Vitonis A. F., Vincent D., Vierkant R. A., Vergote I., Van Den Berg D., Van Altena A. M., Tworoger S. S., Thompson P. J., Tessier D. C., Terry K. L., Teo S. H., Templeman C., Stram D. O., Southey M. C., Sieh W., Siddiqui N., Shvetsov Y. B., Shu X. O., Shridhar V., Wang-Gohrke S., Severi G., Schwaab I., Salvesen H. B., Rzepecka I. K., Runnebaum I. B., Rossing M. A., Rodriguez-Rodriguez L., Risch H. A., Renner S. P., Poole E. M., Pike M. C., Phelan C. M., Pelttari L. M., Pejovic T., Paul J., Orlow I., Omar S. Z., Olson S. H., Odunsi K., Nickels S., Nevanlinna H., Ness R. B., Narod S. A., Nakanishi T., Moysich K. B., Monteiro A. N., Moes-Sosnowska J., Modugno F., Menon U., McLaughlin J. R., McGuire V., Matsuo K., Adenan N. A., Massuger L. F., Lurie G., Lundvall L., Lubinski J., Lissowska J., Levine D. A., Leminen A., Lee A. W., Le N. D., Lambrechts S., Lambrechts D., Kupryjanczyk J., Krakstad C., Konecny G. E., Kjaer S. K., Kiemeney L. A., Kelemen L. E., Keeney G. L., Karlan B. Y., Karevan R., Kalli K. R., Kajiyama H., Ji B. T., Jensen A., Jakubowska A., Iversen E., Hosono S., Hogdall C. K., Hogdall E., Hoatlin M., Hillemanns P., Heitz F., Hein R., Harter P., Halle M. K., Hall P., Gronwald J., Gore M., Goodman M. T., Giles G. G., Gentry-Maharaj A., Garcia-Closas M., Flanagan J. M., Fasching P. A., Ekici A. B., Edwards R., Eccles D., Easton D. F., Durst M., du Bois A., Dork T., Doherty J. A., Despierre E., Dansonka-Mieszkowska A., Cybulski C., Cramer D. W., Cook L. S., Chen X., Charbonneau B., Chang-Claude J., Campbell I., Butzow R., Bunker C. H., Brueggmann D., Brown R., Brooks-Wilson A., Brinton L. A., ogdanova N B., Block M. S., Benjamin E., Beesley J., Beckmann M. W., Bandera E. V., Baglietto L., Bacot F., Armasu S. M., Antonenkova N., Anton-Culver H., Aben K. K., Liang D., Wu X., Lu K., Hildebrandt M. A., Schildkraut J. M., Sellers T. A., Huntsman D., Berchuck A., Chenevix-Trench G., Gayther S. A., Pharoah P. D., Laird P. W., Goode E. L., Pearce C. L., Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications 2013 4 article 1628
45. Pearce C. L., Templeman C., Rossing M. A., Lee A., Near A. M., Webb P. M., Nagle C. M., Doherty J. A., Cushing-Haugen K. L., Wicklund K. G., Chang-Claude J., Hein R., Lurie G., Wilkens L. R., Carney M. E., Goodman M. T., Moysich K., Kjaer S. K., Hogdall E., Jensen A., Goode E. L., Fridley B. L., Larson M. C., Schildkraut J. M., Palmieri R. T., Cramer D. W., Terry K. L., Vitonis A. F., Titus L. J., Ziogas A., Brewster W., Anton-Culver H., Gentry-Maharaj A., Ramus S. J., Anderson A. R., Brueggmann D., Fasching P. A., Gayther S. A., Huntsman D. G., Menon U., Ness R. B., Pike M. C., Risch H., Wu A. H., Berchuck A., Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. The Lancet Oncology 2012 13 4 385 394 2-s2.0-84859162183 10.1016/S1470-2045(11) 70404-1
46. Kurman R. J., McConnell T. G., Characterization and comparison of precursors of ovarian and endometrial carcinoma: parts I and II. International Journal of Surgical Pathology 2010 18 3, supplement 181S 189S 2-s2.0-77955906252
47. Liu J., Albarracin C. T., Chang K.-H., Thompson-Lanza J. A., Zheng W., Gershenson D. M., Broaddus R., Luthra R., Microsatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer. Modern Pathology 2004 17 1 75 80 2-s2.0-2442712044 10.1038/modpathol.3800017 (Pubitemid 41656455)
48. Cai K. Q., Albarracin C., Rosen D., Zhong R., Zheng W., Luthra R., Broaddus R., Liu J., Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma. Human Pathology 2004 35 5 552 559 2-s2.0-2442670288 10.1016/j.humpath.2003.12.009 (Pubitemid 38656938)
49. Wiegand K. C., Shah S. P., Al-Agha O. M., Zhao Y., Tse K., Zeng T., Senz J., McConechy M. K., Anglesio M. S., Kalloger S. E., Yang W., Heravi-Moussavi A., Giuliany R., Chow C., Fee J., Zayed A., Prentice L., Melnyk N., Turashvili G., Delaney A. D., Madore J., Yip S., McPherson A. W., Ha G., Bell L., Fereday S., Tam A., Galletta L., Tonin P. N., Provencher D., Miller D., Jones S. J. M., Moore R. A., Morin G. B., Oloumi A., Boyd N., Aparicio S. A., Shih I.-M., Mes-Masson A.-M., Bowtell D. D., Hirst M., Gilks B., Marra M. A., Huntsman D. G., ARID1A mutations in endometriosis-associated ovarian carcinomas. The New England Journal of Medicine 2010 363 16 1532 1543 2-s2.0-77957946398 10.1056/NEJMoa1008433
50. Jones S., Wang T.-L., Shih I.-M., Mao T.-L., Nakayama K., Roden R., Glas R., Slamon D., Diaz L. A. Jr., Vogelstein B., Kinzler K. W., Velculescu V. E., Papadopoulos N., Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 2010 330 6001 228 231 2-s2.0-77957731999 10.1126/science.1196333
51. Widschwendter M., Apostolidou S., Jones A. A., Fourkala E. O., Arora R., Pearce C. L., Frasco M. A., Ayhan A., Zikan M., Cibula D., Iyibozkurt C. A., Yavuz E., Hauser-Kronberger C., Dubeau L., Menon U., Jacobs I. J., HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: a proof of principle study. International Journal of Cancer 2009 125 9 2214 2218 2-s2.0-70249116811 10.1002/ijc.24599
52. Wu Q., Lothe R. A., Ahlquist T., Silins I., Tropé C. G., Micci F., Nesland J. M., Suo Z., Lind G. E., DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets. Molecular Cancer 2007 6, article 45 2-s2.0-34548535326 10.1186/1476-4598-6-45 (Pubitemid 47381869)
53. Hawighorst T., Velasco P., Streit M., Hong Y.-K., Kyriakides T. R., Brown L. F., Bornstein P., Detmar M., Thrombospondin-2 plays a protective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism. EMBO Journal 2001 20 11 2631 2640 2-s2.0-0035355471 10.1093/emboj/20.11.2631 (Pubitemid 32938548)
54. Czekierdowski A., Czekierdowska S., Danilos J., Czuba B., Sodowski K., Sodowska H., Szymanski M., Kotarski J., Microvessel density and CPG island methylation of THBS2 gene in malignant ovarian tumors. Journal of Physiology and Pharmacology 2008 59 supplement 4 53 65 2-s2.0-53549129493
55. Kodama J., Hashimoto I., Seki N., Hongo A., Yoshinouchi M., Okuda H., Kudo T., Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor. Anticancer Research B 2001 21 4 2983 2987 2-s2.0-0035165350 (Pubitemid 33051163)
56. Lopes N., Gregg D., Vasudevan S., Hassanain H., Goldschmidt-Clermont P., Kovacic H., Thrombospondin 2 regulates cell proliferation induced by Rac1 redox-dependent signaling. Molecular and Cellular Biology 2003 23 15 5401 5408 2-s2.0-0043092648 10.1128/MCB.23.15.5401-5408.2003 (Pubitemid 36950894)
57. Kulasingam V., Pavlou M. P., Diamandis E. P., Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer. Nature Reviews Cancer 2010 10 5 371 378 2-s2.0-77951623830 10.1038/nrc2831
58. Mani R.-S., Iyer M. K., Cao Q., Brenner J. C., Wang L., Ghosh A., Cao X., Lonigro R. J., Tomlins S. A., Varambally S., Chinnaiyan A. M., TMPRSS2-ERG-mediated feed-forward regulation of wild-type ERG in human prostate cancers. Cancer Research 2011 71 16 5387 5392 2-s2.0-80051681322 10.1158/0008-5472.CAN-11-0876
59. Davies M. N., Volta M., Pidsley R., Lunnon K., Dixit A., Lovestone S., Coarfa C., Harris R. A., Milosavljevic A., Troakes C., Al-Sarraj S., Dobson R., Schalkwyk L. C., Mill J., Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biology 2012 13 6 R43
60. Maunakea A. K., Nagarajan R. P., Bilenky M., Ballinger T. J., Dsouza C., Fouse S. D., Johnson B. E., Hong C., Nielsen C., Zhao Y., Turecki G., Delaney A., Varhol R., Thiessen N., Shchors K., Heine V. M., Rowitch D. H., Xing X., Fiore C., Schillebeeckx M., Jones S. J. M., Haussler D., Marra M. A., Hirst M., Wang T., Costello J. F., Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010 466 7303 253 257 2-s2.0-77954504873 10.1038/nature09165
61. Baylin S. B., Jones P. A., A decade of exploring the cancer epigenome-biological and translational implications. Nature Reviews Cancer 2011 11 10 726 734 2-s2.0-80053144962 10.1038/nrc3130
62. Medvedeva Y. A., Fridman M. V., Oparina N. J., Malko D. B., Ermakova E. O., Kulakovskiy I. V., Heinzel A., Makeev V. J., Intergenic, gene terminal, and intragenic CpG islands in the human genome. BMC Genomics 2010 11 1, article 48 2-s2.0-76749135286 10.1186/1471-2164-11-48
63. Gardiner-Garden M., Frommer M., CpG islands in vertebrate genomes. Journal of Molecular Biology 1987 196 2 261 282 2-s2.0-0023216891 (Pubitemid 17122132)
64. Meyerson M., Gabriel S., Getz G., Advances in understanding cancer genomes through second-generation sequencing. Nature Reviews Genetics 2010 11 10 685 696 2-s2.0-77956838065 10.1038/nrg2841
65. Wang T., Zeng J., Lowe C. B., Sellers R. G., Salama S. R., Yang M., Burgess S. M., Brachmann R. K., Haussler D., Species-specific endogenous retroviruses shape the transcriptional network of the human tumor suppressor protein p53. Proceedings of the National Academy of Sciences of the United States of America 2007 104 47 18613 18618 2-s2.0-36749061982 10.1073/pnas.0703637104 (Pubitemid 350210745)
66. Bourque G., Transposable elements in gene regulation and in the evolution of vertebrate genomes. Current Opinion in Genetics and Development 2009 19 6 607 612 2-s2.0-71749094924 10.1016/j.gde.2009.10.013
67. Chanock S. J., Manolio T., Boehnke M., Boerwinkle E., Hunter D. J., Thomas G., Hirschhorn J. N., Abecasis G., Altshuler D., Bailey-Wilson J. E., Brooks L. D., Cardon L. R., Daly M., Donnelly P., Fraumeni J. F. Jr., Freimer N. B., Gerhard D. S., Gunter C., Guttmacher A. E., Guyer M. S., Harris E. L., Hoh J., Hoover R., Kong C. A., Merikangas K. R., Morton C. C., Palmer L. J., Phimister E. G., Rice J. P., Roberts J., Rotimi C., Tucker M. A., Vogan K. J., Wacholder S., Wijsman E. M., Winn D. M., Collins F. S., Replicating genotype-phenotype associations. Nature 2007 447 7145 655 660 2-s2.0-34249997024 10.1038/447655a (Pubitemid 46889722)